Chugai Pharmaceutical Co., Ltd. Company Profile

Chugai Pharmaceutical Co., Ltd.

2-1-9, Kyobashi
Chuo-ku, Tokyo 104-8301
Japan
Tel: 81/3/3281/6611
URL: http://www.chugai-pharm.co.jp
Primary Symbol & Exchange:
4519 - Ordinary Shares - Tokyo
Industry:
Pharmaceutical
+  SIC Industry Code:
+  NAICS Industry Code:
Mergers & Acquisitions:
Chugai Pharmaceutical Co., Ltd. Mergers and Acquisitions
Thomson Financial Business Description:
The Group's principal activity is to manufacture pharmaceutical products. The products include prescription medicines for central nervous, cardiovascular, respiratory, gastrointestinal and metabolic systems, hormones and diagnostic products and OTC drugs. The operations are carried out through the following divisions: Pharmaceuticals and Other operations. The major products are epogin, alfarol, neutrogin, sigmart , suvenyl, oxarol, rocephin, renagel and rythmodan.
Alacra Alerts: Chugai Pharmaceutical Co., Ltd. RSS Feed  Subscribe with My Yahoo!
Receive alerts on the latest reports on Chugai Pharmaceutical Co., Ltd.

Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.

Premium Content Results:







Search for more premium content on Chugai Pharmaceutical Co., Ltd.